Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 3 results.

- Journal article
Clinical activity and benefit of irinotecan (CPT-11) in patients with colorectal cancer truly resistant to 5-fluorouracil (5-FU)
Van Cutsem, E. Cunningham, D. Huinink, WWT. Punt, CJA Alexopoulos, C.G. Dirix, L. Symann, Michel[UCL] Blijham, GH Cholet, P Fillet, G. Van Groeningen, C Vannetzel, JM Levi, F Panagos, G Unger, C. Wils, J. Cote, C Blanc, C Herait, P Bleiberg, H. (1999) European Journal of Cancer — Vol. 35, no. 1, p. 54-59 (1999)
- Speech
CPT11 alternating with 5 fluorouracil (5 FU) folinic acid (FA): A multicentre phase II study in 1st line chemotherapy (CT) of metastatic colorectal cancer (CRC): Preliminary results
Barone, C Humblet, Yves[UCL] Pozzo, C Starkhammar, H Terzoli, E Garufi, C Dirix, L. Cognetti, F Fages, B Cote, C VanCutsem, E (1997) —
- Journal article
A phase II study of irinotecan alternated with five days bolus of 5-fluorouracil and leucovorin in first-line chemotherapy of metastatic colorectal cancer
Van Cutsem, E. Humblet, Yves[UCL] Pozzo, C Starkhammar, H Dirix, L. Terzoli, E Cognetti, E Garufi, C Filez, L Gruia, G Cote, C Barone, C (1998) Annals of Oncology — Vol. 9, no. 11, p. 1199-1204 (1998)